Tracheal, Bronchus, and Lung Cancer: GBD 2019
Disease Overview
The trachea, commonly referred to as the windpipe, is part of the lower respiratory tract that connects the larynx (lower portion of the upper respiratory tract) to the primary bronchi, which biforcate from the trachea and lead to each lung. Most cases of tracheal and bronchus cancer are secondary to primary cancer in other sites; however, primary cancers can occur in these sites as well [Sherani-et-al-2015-LC], [Javidan-Nejad-2010-LC]. Notably, tracheal cancer makes up only a small portion of tracheal, bronchus, and lung cancers [Sherani-et-al-2015-LC], [Javidan-Nejad-2010-LC].
Lung cancer screening and diagnosis is performed via low-dose computed topography (LDCT), which provides an image of the chest. Screening guidelines typically depend on age, smoking history, and current health status. Bronchus and tracheal cancer diagnoses are performed using LDCT as well as bronchioscopy (or a scope of the respiratory tract) [Sherani-et-al-2015-LC], [Javidan-Nejad-2010-LC].
Risk factors for lung cancer include genetic and environmental factors, notably tobacco smoke and air pollution. Despite advances in TCL cancer early detection and therapy options, its burden is still increasing due to an aging popuation and risk factors such as smoking history [Deng-et-al-2020-LC].
GBD 2019 Modeling Strategy
Cause Hierarchy
Restrictions
The following table describes any restrictions in GBD 2019 on the effects of this cause (such as being only fatal or only nonfatal), as well as restrictions on the ages and sexes to which the cause applies.
Restriction Type |
Value |
Notes |
|---|---|---|
Male only |
||
Female only |
||
YLL only |
||
YLD only |
||
YLL age group start |
||
YLL age group end |
||
YLD age group start |
||
YLD age group end |
Vivarium Modeling Strategy
Todo
Add an overview of the Vivarium modeling section.
Scope
Todo
Describe which aspects of the disease this cause model is designed to simulate, and which aspects it is not designed to simulate.
Assumptions and Limitations
Todo
Describe the clinical and mathematical assumptions made for this cause model, and the limitations these assumptions impose on the applicability of the model.
Cause Model Diagram
State and Transition Data Tables
This section gives necessary information to software engineers for building the model. This section usually contains four tables: Definitions, State Data, Transition Data and Data Sources.
Definitions
This table contains the definitions of all the states in cause model diagram.
State |
State Name |
Definition |
|---|---|---|
States Data
This table contains the measures and their values for each state in cause-model diagram. This information is used to initialize the model.
State |
Measure |
Value |
Notes |
|---|---|---|---|
State |
prevalence |
||
State |
birth prevalence |
||
State |
excess mortality rate |
||
State |
disabilty weights |
||
ALL |
cause specific mortality rate |
Transition Data
This table contains the measures needed for transition from one state to other in the cause model.
Transition |
Source |
Sink |
Value |
Notes |
|---|---|---|---|---|
i |
S |
I |
||
r |
I |
R |
Data Sources
This table contains the data sources for all the measures. The table structure and common measures are as below:
Measure |
Sources |
Description |
Notes |
|---|---|---|---|
prevalence_cid |
|||
birth_prevalence_cid |
|||
deaths_cid |
|||
population |
|||
sequelae_cid |
|||
incidence_rate_cid |
|||
remission_rate_mid |
|||
disability_weight_s{sid} |
|||
prevalence_s{sid} |
Validation Criteria
References
Deng, Yujiao, et al. “Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.” Journal of hematology & oncology 13.1 (2020): 1-16. Available here
Javidan-Nejad, Cylen. “MDCT of trachea and main bronchi.” Radiologic Clinics 48.1 (2010): 157-176. Available here
Sherani, Khalid, et al. “Malignant tracheal tumors: a review of current diagnostic and management strategies.” Current Opinion in Pulmonary Medicine 21.4 (2015): 322-326. Available here